Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
35197325
Public Release Type:
Journal
Publication Year: 2022
DOI:
https://doi.org/10.1681/ASN.2021060774
Authors:
Vlasschaert Caitlyn, McNaughton Amy J.M., Chong Michael, Cook Elina K., Hopman Wilma, Kestenbaum Bryan, Robinson-Cohen Cassianne, Garland Jocelyn, Moran Sarah M., Paré Guillaume, Clase Catherine M., Tang Mila, Levin Adeera, Holden Rachel, Rauh Michael J., Lanktree Matthew B.
Request IDs:
21173
,
22012
,
22016
Studies:
Chronic Renal Insufficiency Cohort Study
Clonal hematopoiesis of indeterminate potential (CHIP), a premalignant expansion of clonal leukocytes caused by acquired somatic mutations in myeloid stem/progenitor cells, occurs in 10%–15% of the general population aged 65 years or older. This proinflammatory condition appears causally associated with cardiovascular disease and death. The authors found that 43 of 172 (25%) individuals with advanced CKD had CHIP. Those with CHIP had a 2.2-fold greater risk of kidney failure over 5 years of follow-up and were more likely to have complications of CKD (including anemia) compared with those without CHIP. More research, including studies in animal models, is needed to understand the relationship between CHIP and CKD. CHIP-related inflammation might offer a novel therapeutic target for those with CHIP and CKD.
